Capstone Investment Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-736
| Closed | -$227K | – | 1035 |
|
|
2025
Q1 | $227K | Buy |
+736
| New | +$227K | ﹤0.01% | 481 |
|
|
2024
Q4 | – | Sell |
-812
| Closed | -$291K | – | 931 |
|
|
2024
Q3 | $291K | Sell |
812
-252
| -24% | -$90.3K | ﹤0.01% | 560 |
|
|
2024
Q2 | $339K | Sell |
1,064
-3,998
| -79% | -$1.27M | ﹤0.01% | 712 |
|
|
2024
Q1 | $1.16M | Buy |
5,062
+2,410
| +91% | +$554K | ﹤0.01% | 485 |
|
|
2023
Q4 | $583K | Buy |
2,652
+778
| +42% | +$171K | ﹤0.01% | 470 |
|
|
2023
Q3 | $423K | Buy |
+1,874
| New | +$423K | ﹤0.01% | 650 |
|
|
2017
Q4 | – | Sell |
-5,799
| Closed | -$679K | – | 552 |
|
|
2017
Q3 | $679K | Buy |
+5,799
| New | +$679K | 0.02% | 181 |
|
|
2016
Q3 | – | Sell |
-8,807
| Closed | -$932K | – | 796 |
|
|
2016
Q2 | $932K | Buy |
8,807
+4,807
| +120% | +$509K | 0.02% | 285 |
|
|
2016
Q1 | $445K | Buy |
+4,000
| New | +$445K | 0.01% | 377 |
|